Put companies on watchlist
Aspermont Ltd
ISIN: AU000000ASP3
WKN: A0NGFS
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

Aspermont Ltd · ISIN: AU000000ASP3 · EQS - Analysts (20 News)
Country: Germany · Primary market: Australia · EQS NID: 16135
07 December 2022 12:02PM

Kaufen


Original-Research: Aspermont Ltd - von GBC AG

Einstufung von GBC AG zu Aspermont Ltd

Unternehmen: Aspermont Ltd
ISIN: AU000000ASP3

Anlass der Studie: Research Update
Empfehlung: Kaufen
Kursziel: 0.11 AUD
Kursziel auf Sicht von: 30.09.2023
Letzte Ratingänderung:
Analyst: Julien Desrosiers, Matthias Greiffenberger

FY-2022 preliminary report shows increased growth  
The following are some of the company's highlights: -Total revenue +17% at $18.7m
-Gross profit +15% at $12m, with gross margins of 64% -EBITDA +40% at $2.3m with margin of 12% -Ana Gyorkos joined Aspermont as the Group Content Director -Soochow CSSD Capital Markets retained as corporate adviser  
The company has drastically improved their growth rate compared to historical results.
 
The growth rate has reached pre-COVID levels with revenues of over 18.7m. At the current cumulated rate, the company could grow at an accelerated 20% growth rate for FY2023e.
 
The company has also noticeably improved their recurring revenues to 75% up from 70%.
 
The company has now accumulated 25 consecutive growth quarters and generated positive return for shareholders over the past five years.  
Most importantly, the company is increasing their internal investments directly out of their cash flow and cash reserves. The company remains very strong financially with cash on hand of $6.6m and long-term debt free.  
We will be updating our valuation when the company publishes their FY financials in the next few weeks. We are therefore maintaining our BUY rating and our target price of 0.11 AUD / 0.08 EUR.  

Die vollständige Analyse können Sie hier downloaden: http://www.more-ir.de/d/26135.pdf

Kontakt für Rückfragen
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG und Art. 20 MAR Beim oben analysierten Unternehmen ist folgender möglicher Interessenkonflikt gegeben: (5a,11); Einen Katalog möglicher Interessenkonflikte finden Sie unter: http://www.gbc-ag.de/de/Offenlegung
+++++++++++++++
Date (time) Completion: 06.12.2022 (17:30 am) Date (time) first transmission: 07.12.2022 (12.00 am)

-------------------übermittelt durch die EQS Group AG.-------------------

Für den Inhalt der Mitteilung bzw. Research ist alleine der Herausgeber bzw. Ersteller der Studie verantwortlich. Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.

Visual performance / price development - Aspermont Ltd
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.